NewslettersCancer Stem Cell NewsA Novel Lonidamine Derivative Targeting Mitochondria to Eliminate Cancer Stem Cells by Blocking Glutamine MetabolismBy Bob - March 28, 20230214Investigators reported a novel derivative of lonidamine, namely HYL001, which selectively and potently inhibited CSCs by targeting mitochondria.[Pharmacological Research]Full ArticleGraphical Abstract